Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

ANTIDOTE THERAPEUTICS INC — Funding, Investors & Profile — Capbase

← All companies

Compare History

ANTIDOTE THERAPEUTICS INC

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: KNPKVDXDCNL9

Founded: —Source: [GOV]
Headquarters: SYKESVILLE, MarylandSource: [GOV]
Country: United StatesSource: [GOV]
Headcount: 1Source: [GOV]
Stage

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

ANTIDOTE THERAPEUTICS INC has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $200,834 in 2017. These are non-dilutive federal research grants, not equity financing. The company is based in SYKESVILLE, Maryland.

Funding rounds

1 rounds

1 round · latest SBIR Phase I award (HHS), Apr 2017

Investors

No investors recorded yet for ANTIDOTE THERAPEUTICS INC.

Add an investor

People

Leadership

MATTHEW W KALNIKPrincipal investigatorSince 2017Source: [GOV]

Acquisitions

ANTIDOTE THERAPEUTICS INC has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for ANTIDOTE THERAPEUTICS INC.

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Seed

Sector

Healthcare